Xilio Therapeutics, Inc. — All Filings
326 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-K/A
10-Q
10-Q/A
3
4
4/A
424B4
424B5
8-A12B
8-K
ARS
CERT
CORRESP
D
DEF 14A
DEFA14A
DRS
DRS/A
DRSLTR
EFFECT
PRE 14A
S-1
S-1/A
S-3
S-3/A
S-8
SC 13D
SC 13G
SC 13G/A
SCHEDULE 13G
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| S-8 | S-8 | 0001193125-26-118559 | Mar 23, 2026 | — |
| 10-K | 10-K | 0001193125-26-118550 | Mar 23, 2026 | Dec 31, 2025 |
| 8-K | 8-K | 0001193125-26-118544 | Mar 23, 2026 | — |
| 8-K | 8-K | 0001193125-26-103150 | Mar 12, 2026 | — |
| 8-K | 8-K | 0001193125-26-097603 | Mar 9, 2026 | — |
| 8-K | 8-K | 0001193125-26-065234 | Feb 24, 2026 | Feb 23, 2026 |
| SCHEDULE 13G/A | — | 0001193125-26-054804 | Feb 17, 2026 | — |
| SCHEDULE 13G/A | — | 0001104659-26-015985 | Feb 17, 2026 | — |
| SCHEDULE 13G/A | — | 0001231919-26-000149 | Feb 13, 2026 | — |
| 8-K | 8-K | 0001193125-26-048942 | Feb 12, 2026 | Feb 11, 2026 |
| 424B5 | 424B5 | 0001193125-26-048934 | Feb 12, 2026 | — |
| 424B5 | 424B5 | 0001193125-26-046842 | Feb 11, 2026 | — |
| DEF 14A | DEF 14A | 0001193125-26-021691 | Jan 26, 2026 | Feb 23, 2026 |
| PRE 14A | PRE 14A | 0001193125-26-015343 | Jan 16, 2026 | — |
| 8-K | 8-K | 0001193125-26-007063 | Jan 8, 2026 | Jan 6, 2026 |
| 4 | 4 | 0001193125-26-002518 | Jan 5, 2026 | Dec 31, 2025 |
| 4 | 4 | 0001193125-26-002520 | Jan 5, 2026 | Dec 31, 2025 |
| 8-K | 8-K | 0001193125-26-001580 | Jan 5, 2026 | — |
| 4 | 4 | 0001193125-26-002512 | Jan 5, 2026 | Dec 31, 2025 |
| 4 | 4 | 0001193125-26-002517 | Jan 5, 2026 | Dec 31, 2025 |
| SCHEDULE 13G | — | 0001104659-25-120365 | Dec 11, 2025 | — |
| S-8 | S-8 | 0001193125-25-297243 | Nov 25, 2025 | — |
| 4 | 4 | 0001193125-25-297204 | Nov 25, 2025 | Nov 21, 2025 |
| 8-K | 8-K | 0001193125-25-297165 | Nov 25, 2025 | Nov 21, 2025 |
| 4 | 4 | 0001193125-25-297203 | Nov 25, 2025 | Nov 21, 2025 |
| 4 | 4 | 0001193125-25-297205 | Nov 25, 2025 | Nov 21, 2025 |
| 4 | 4 | 0001193125-25-297207 | Nov 25, 2025 | Nov 21, 2025 |
| SCHEDULE 13G | — | 0001104659-25-112051 | Nov 14, 2025 | — |
| SCHEDULE 13G/A | — | 0000902664-25-004986 | Nov 14, 2025 | — |
| 8-K | 8-K | 0001193125-25-278835 | Nov 13, 2025 | — |
| 10-Q | 10-Q | 0001193125-25-278837 | Nov 13, 2025 | Sep 30, 2025 |
| 8-K | 8-K | 0001193125-25-271189 | Nov 7, 2025 | — |
| DEF 14A | DEF 14A | 0001193125-25-243037 | Oct 20, 2025 | Nov 21, 2025 |
| PRE 14A | PRE 14A | 0001193125-25-237064 | Oct 10, 2025 | Nov 21, 2025 |
| 8-K | 8-K | 0001193125-25-229231 | Oct 3, 2025 | Oct 2, 2025 |
| 8-K | 8-K | 0001558370-25-011949 | Sep 9, 2025 | — |
| 8-K | 8-K | 0001558370-25-011802 | Aug 28, 2025 | Aug 22, 2025 |
| 10-Q | 10-Q | 0001558370-25-011477 | Aug 14, 2025 | Jun 30, 2025 |
| SCHEDULE 13G/A | — | 0001415889-25-021802 | Aug 14, 2025 | — |
| 8-K | 8-K | 0001558370-25-011473 | Aug 14, 2025 | — |
| 4 | — | 0001415889-25-017704 | Jun 18, 2025 | Jun 16, 2025 |
| 4 | — | 0001415889-25-017705 | Jun 18, 2025 | Jun 16, 2025 |
| 4/A | — | 0001415889-25-017703 | Jun 18, 2025 | Jan 1, 2025 |
| SCHEDULE 13G | — | 0000902664-25-002744 | Jun 17, 2025 | — |
| 4 | — | 0001415889-25-016968 | Jun 12, 2025 | Jun 11, 2025 |
| 4 | — | 0001415889-25-016969 | Jun 12, 2025 | Jun 11, 2025 |
| 4 | — | 0001415889-25-016970 | Jun 12, 2025 | Jun 11, 2025 |
| 4 | — | 0001415889-25-016971 | Jun 12, 2025 | Jun 11, 2025 |
| 4 | — | 0001415889-25-016972 | Jun 12, 2025 | Jun 11, 2025 |
| SCHEDULE 13G | — | 0001415889-25-016985 | Jun 12, 2025 | — |